**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 2923-28-6 |Silver trifluoromethanesulfonate | 99+ | 220-882-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological
properties of this material have not been fully investigated.Light
sensitive.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May cause skin discoloration.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
The toxicological properties of this substance have not been fully
investigated. Causes upper respiratory tract irritation. Causes
irritation of the mucous membrane.
Chronic:
Chronic effects include excessive calcification of the bones,
ligaments, and tendons. Chronic inhalation or ingestion of silver
salts may cause argyria characterized by a permanent blue-gray
discoloration of the eyes, skin, mucous membranes, and internal
organs. This malady results from the accumulation of silver in the
body.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Do NOT get water inside containers. Use water spray, dry chemical,
carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Do not get water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Store protected from light. Do not allow contact with
water. Keep from contact with moist air and steam.
Storage:
Store in a tightly closed container. Keep under a nitrogen blanket.
Store in a cool, dry, well-ventilated area away from incompatible
substances. Store protected from moisture. Store protected from
light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 2923-28-6:
Japan: (listed as silver compounds): 0.01 mg/m3 OEL (as Ag)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Odorless.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 356 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: 101g/100g
Specific Gravity/Density:
Molecular Formula: CF3O3SAg
Molecular Weight: 256.92
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat, exposure
to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents, moisture.
Hazardous Decomposition Products:
Carbon monoxide, oxides of sulfur, irritating and toxic fumes and
gases, carbon dioxide, hydrogen fluoride gas, oxides of silver.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 2923-28-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Silver trifluoromethanesulfonate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 2923-28-6: No information available.
Canada
CAS# 2923-28-6 is listed on Canada's NDSL List.
CAS# 2923-28-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2923-28-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/28/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Sulfamic acid
| 5329-14-6 |
|
3-Chlorocinnamic Acid, Predominantly Trans 99+%
| 1866-38-2 |
|
4-(Bromomethyl)-7-Methoxycoumarin 99%
| 35231-44-8 |
|
2-Hydroxy-3-nitropyridine, 98%
| 6332-56-5 |
|
Sulfanilamide
| 63-74-1 |
|
Sulfanilic acid
| 121-57-3 |
|
Nicotine sulfate, 40% aqueous solution
| 65-30-5 |
|
2-Bromobenzaldehyde, 97%
| 6630-33-7 |
|
Bicyclo (3.2.1)Octan-2-One, 90-95%(GC)
| 5019-82-9 |
|
Benzo??b??naphtho??2,3-d??thiophene, 99.5+%
| 243-46-9 |
|
Triethyl Orthoacetate, 99% (GC)
| 78-39-7 |
|
5-Sulfosalicylic acid dihydrate
| 97-05-2 |
|
4-Benzoyloxy-2-Azetidinone, 99%
| 28562-58-5 |
|
Sulfur (Precipitated and Sublimed)
| 7704-34-9 |
|
N-Methyl-Beta-Alaninenitrile, 98%
| 693-02-7 |
|
Trimethyl Orthovalerate
| 13820-09-2 |
|
Ethyl diethoxyphosphinylformate, 98%
| 1474-78-8 |
|
S-Methyl-L-Cysteine, 99+%
| 1187-84-4 |
|
N-Benzoyl-4-Piperidone, 97%
| 24686-78-0 |
|
Succinimide, 99%
| 123-56-8 |
|
Sulfuric acid 90-98%
| 7664-93-9 |
|
Sulfurous Acid
| 7782-99-2 |
|
Silver trifluoromethanesulfonate, 99+%
| 2923-28-6 |
|
Rhodanine-n-acetic acid, 98%
| 5718-83-2 |
|
Tannic Acid
| 1401-55-4 |
|
Diphenic Anhydride, 98%
| 6050-13-1 |
|
4-(Dimethylamino)butyric Acid Hydrochloride, 98%
| 69954-66-1 |
|
(4S,5S)-4,5-Di(aminomethyl)-2,2-dimethyldioxolane, 99+%
| 119322-88-2 |
|
4-Acryloylamidobenzo-18-Crown-6, 98%
| 0-00-1 |
|
2-Thio-6-hydroxypurine hydrate, 98%
| 2487-40-3 |
|
3-Methyl-4-nitrobenzoic acid, 99%
| 3113-71-1 |
|
L-(+)-Tartaric acid
| 87-69-4 |
|
3-Methyl-2-pyrazolin-5-one, 99% (titr.)
| 108-26-9 |
|
2-Nitronaphthalene, tech., 85%
| 581-89-5 |
|
2,6-Dibromopyridine, 98%
| 626-05-1 |
|
5-Methylfurfural, 98+%
| 620-02-0 |
|
Ammonium orthoarsenate trihydrate, 99.999%
| 13477-86-6 |
|
n-Benzylglycine ethyl ester hydrochloride, 98%
| |
|
N-Alpha-Acetyl-L-Lysine-N-Methylamide Monohydrate, 99+%, (TLC)
| 81013-00-5 |
|
(+)-Dimethyl L-Tartrate, 99%
| 608-68-4 |
|
2,5-Dibromotoluene, 99%
| 615-59-8 |
|
2-Aminoperimidine, Hydrobromide Sesquihydrate, 98%
| 40835-96-9 |
|
Nucleic Acid (Pract), 90% (UV-VIS)
| 9008-72-4 |
|
Ethyl 3-Endo-Aminobicyclo[2.2.1]Hept-5-ene -2-Endo-Carboxylate
| 95630-74-3 |
|
Cyclopentanemethanol, 96%
| 3637-61-4 |
|
Tetrahexylammonium Bromide, 99% (Titr.)
| 4328-13-6 |
|
1-(4-Chlorophenyl)-1-cyclohexanecarbonitrile
| |
|
Potassium deuteroxide, 40 wt% solution in d2o, 98+ atom % d
| 24572-01-8 |
|
1-(2-Methoxyphenyl)piperazine, 98+% (GC)
| 35386-24-4 |
|
4-Carboxybenzo-15-Crown-5, 99+%
| 0-00-1 |
|
|